Midwest Cancer Alliance Partners with AONN+ to Advance Oncology Navigation

March 2018 Vol 9, No 3


In the News

The Midwest Cancer Alliance (MCA), the outreach network of The University of Kansas Cancer Center (KUCC), has partnered with the Academy of Oncology Nurse & Patient Navigators (AONN+) to enhance the skills of MCA-member oncology nurse navigators. The KUCC is the only National Cancer Institute–designated cancer center in Kansas, and the MCA links member hospitals, medical professionals, and their patients with KUCC research and services. The MCA network includes more than 60 patient and nurse navigators across the Midwest (Figure).


The AONN+ and MCA will offer membership in the academy to clinical nurse and patient navigators in the MCA system as well as oncology nurse navigator certification as part of the MCA’s ongoing commitment to providing navigation services within their institutions and in rural communities. The AONN+ and MCA will collaborate on developing navigation education and resources for MCA navigators.

Executives from both organizations expressed their enthusiasm for the new partnership. “We are delighted to have the navigators from the Midwest Cancer Alliance join us,” said Lillie D. Shockney, RN, BS, MAS, ONN-CG, Co-Founder and Program Director, AONN+. And MCA Executive Director, Hope Krebill, MSW, BSN, RN, said, “Our partnership with AONN is a great addition to the tools and resources Midwest Cancer Alliance offers our medical colleagues.”

“The growth of navigation as a profession is exciting and gratifying. To bring yet another institution on board is further evidence that navigation tactics help institutions reach their goals of providing value-based, effective patient care,” said AONN+’s Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer and Senior Director of Strategic Planning and Initiatives.

Related Articles
Government Shutdown Impacts FDA Drug Approvals
News and Updates
Now in its fourth week, the longest shutdown in the history of the federal government is having an impact on patient care, as the US Food and Drug Administration (FDA) has put drug reviews and approvals for new drugs and devices, as well as the issuance of new guidance documents, on indefinite hold.
Danelle Johnston, MSN, RN, ONN-CG, OCN, of AONN+ Appointed to the Biden Cancer Initiative Advisory Committee
Kristin Siyahian
May 2018 Vol 9, No 5
Participating in a national conversation on improving cancer care is a great honor. We are being asked to reconsider how we address cancer from prevention through survivorship. It’s a huge undertaking, but a very exciting one. I’m delighted to be a part of it.” - Danelle Johnston, MSN, RN, ONN-CG, OCN
FDA Opens Way for You to Test for Cancer Risk by Mail
Thomas M. Burton
May 2018 Vol 9, No 5
Federal health officials this week allowed a genetic testing firm to sell kits to consumers to test whether they carry gene mutations that put them at higher risk for breast and ovarian cancer.
Last modified: June 8, 2018

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
  • Please enter your mailing address.

    Address Line 2
    Zip Code